New AI tool aims to ease prostate cancer diagnostic workload
Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created…
International urology conference showcases advancements in prostate cancer diagnostics
Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association…
New fragmentome technology can detect early liver fibrosis and cirrhosis
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free…
A standard practice for colonoscopy completion
Background and objectives Terminal ileum intubation is considered the completion step of colonoscopy and is usually performed to…
Menstrual blood HPV testing accurately detects cervical precancer
A simple menstrual pad may offer a scalable, non-invasive way to expand cervical cancer screening, matching the accuracy…
The future of cancer detection could be just a blood test away, say scientists
The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects…
Landmark prostate cancer screening trial launches in the UK
The first men have been invited to take part in Prostate Cancer UK’s TRANSFORM trial, kicking off the…
Routine liquid biopsy testing could reduce late-stage cancer diagnoses
Routine screening is limited to only a few cancer types. New research indicates that routine liquid biopsy testing…
Pediatric patients with primary glomerular diseases may experience faster kidney function decline
New research reveals that contrary toconventional belief, primary glomerular diseases are not necessarily benign for children and young adults. In fact, some subsets…
Study confirms PSA screening improves survival and safety
The 23-year ERSPC trial reveals that sustained, protocolized PSA testing lowers prostate cancer deaths and improves the benefit-to-harm…
Owlstone Medical wins up to $49.1 million award from ARPA-H to develop at-home multi-cancer-early detection tests
Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine,…
Groundbreaking tool could transform acute leukemia diagnosis and treatment
Researchers at Dana-Farber Cancer Institute have developed a groundbreaking diagnostic tool that could transform the way acute leukemia is identified…